Prairie Advisory’s AbbVie ABBV Stock Holding History

Prairie Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Buy	+1,017	New	+$219K	0.06%	148

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Prairie Advisory's ABBV Position: Q2 2026 in Review

Prairie Advisory opened a new position in AbbVie (ABBV) in Q2 2026: 1,017 shares worth $256K. The stake represents 0.06% of the portfolio and ranks #148 among its holdings.

1,174 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Prairie Advisory held 1,017 shares of AbbVie worth $256K as of Q2 2026.
AbbVie was a new Prairie Advisory position in Q2 2026.
AbbVie made up 0.06% of Prairie Advisory's portfolio in Q2 2026, its #148 holding.
1,174 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Prairie Advisory's 13F filing for Q2 2026, filed 20 Jul 2026.